Patents Assigned to Astron Research Limited
  • STABLE READY-TO-USE CETRORELIX INJECTION
    Publication number: 20130303464
    Abstract: The present invention discloses a stable ready-to-use aqueous pharmaceutical preparation containing Cetrorelix or its pharmaceutically acceptable salt, wherein the preparation does not contain any surfactant. Further, the present invention discloses process for the preparation of said stable ready-to-use aqueous pharmaceutical preparation.
    Type: Application
    Filed: December 5, 2011
    Publication date: November 14, 2013
    Applicant: Astron Research Limited
    Inventors: Pankaj Patel, Bhavesh Patel, Ashish Sehgal, Jayanta Kumar Mandal
  • STABLE TEMSIROLIMUS COMPOSITION AND PROCESS OF PREPARING SAME
    Publication number: 20120252835
    Abstract: The present disclosure describes a stable composition of Temsirolimus for parenteral administration. The composition includes BHA or BHT as anti-oxidants and alcoholic solvent. The pH of the composition is below 5.0. The composition also can include a chelating agent and/or a surfactant. A method of producing the composition is also described.
    Type: Application
    Filed: March 27, 2012
    Publication date: October 4, 2012
    Applicant: ASTRON RESEARCH LIMITED
    Inventors: Harsh RAJPUT, Sandeep MEHTA, Pankaj PATEL, Bhavesh PATEL, Ashish SEHGAL, Jayanta Kumar MANDAL
  • STABLE COMPOSITION OF READY-TO-USE GEMCITABINE INJECTION
    Publication number: 20120129799
    Abstract: The present invention relates to non aqueous pharmaceutical preparations containing gemcitabine or its pharmaceutically, acceptable salts in the form of ready-to-use solutions wherein the concentration of Gemcitabine is in the range of about 16 mg/ml to about 200 mg/ml and a pH of about 3.5 to 10.0. Further, a method for the preparation of non-aqueous Gemcitabine solution of the present invention is also disclosed.
    Type: Application
    Filed: July 29, 2010
    Publication date: May 24, 2012
    Applicant: ASTRON RESEARCH LIMITED
    Inventors: Bothra Mukesh, Patel Bhavesh, Sehgal Ashish, Kumar Mandal Jayanta
  • In-vitro method for testing bioequivalence of iron-sucrose formulation
    Patent number: 8058076
    Abstract: The present disclosure relates to an in vitro method for measuring the T75 of reduction kinetics of iron from Fe+3 to Fe+2 in an iron-sucrose complex and hence assessing the bioequivalency of iron-sucrose composition. According to the disclosed method, T75 of reduction kinetics of iron in an iron-sucrose complex in between 25 to 50 minutes indicates bioequivalent iron-sucrose composition.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: November 15, 2011
    Assignee: Astron Research Limited
    Inventors: Samir Shah, Keyur Patel, Sanjay Dash, Kuldeep Dilip Karnik, Ashish Sehgal, Bhavesh Vallabhabhai Patel, Jayanta Kumar Mandal
  • IN-VITRO METHOD FOR TESTING BIOEQUIVALENCE OF IRON-SUCROSE FORMULATION
    Publication number: 20100248376
    Abstract: The present disclosure relates to an in vitro method for measuring the T75 of reduction kinetics of iron from Fe+3 to Fe+2 in an iron-sucrose complex and hence assessing the bioequivalency of iron-sucrose composition. According to the disclosed method, T75 of reduction kinetics of iron in an iron-sucrose complex in between 25 to 50 minutes indicates bioequivalent iron-sucrose composition.
    Type: Application
    Filed: March 29, 2010
    Publication date: September 30, 2010
    Applicant: ASTRON RESEARCH LIMITED
    Inventors: Samir SHAH, Keyur PATEL, Sanjay DASH, Kuldeep Dilip KARNIK, Ashish SEHGAL, Bhavesh Vallabhabhai PATEL, Jayanta Kumar MANDAL
  • SUSTAINED RELEASE DOSAGE FORM OF PHENOTHIAZINE DERIVATIVES CONTAINING CHANNELIZER
    Publication number: 20100178333
    Abstract: Once a day sustained release solid oral dosage form of phenothiazine derivative preferably the dibenzothiazepine derivative and their pharmaceutically acceptable salts comprising of a channelizer, rate controlling polymer and suitable pharmaceutically acceptable excipients. The formulation of the present invention is in the form of tablet or capsule which provides a sustained drug action upto 24 hours upon single dose administration.
    Type: Application
    Filed: January 23, 2007
    Publication date: July 15, 2010
    Applicant: ASTRON RESEARCH LIMITED
    Inventors: Jayanta Kumar Mandal, Nitesh Nalinchandra Pandya, Kirti Bansidhar Maheshwari
  • Modified release oral dosage form using co-polymer of polyvinyl acetate
    Patent number: 7427414
    Abstract: Once a day modified release oral dosage form comprising of granules or pellets which are either compressed into tablet or filled inside the capsule, wherein the pellet has a core of active ingredient coated on non pareil seeds with a rate controlling functional coating of co-polymer of polyvinyl acetate optionally with an intermediate separating coating between the core and the functional coating layer.
    Type: Grant
    Filed: January 16, 2007
    Date of Patent: September 23, 2008
    Assignee: Astron Research Limited
    Inventors: Shashank Bababhai Patel, Kamala Sultansingh Yadav, Jayant Kumar Mandal, Kirti Bansidhar Maheshwari
  • MODIFIED RELEASE ORAL DOSAGE FORM USING CO-POLYMER OF POLYVINYL ACETATE
    Publication number: 20070166375
    Abstract: Once a day modified release oral dosage form comprising of granules or pellets which are either compressed into tablet or filled inside the capsule, wherein the pellet has a core of active ingredient coated on non pareil seeds with a rate controlling functional coating of co-polymer of polyvinyl acetate optionally with an intermediate separating coating between the core and the functional coating layer.
    Type: Application
    Filed: January 16, 2007
    Publication date: July 19, 2007
    Applicant: ASTRON RESEARCH LIMITED
    Inventors: Shashank Bababhai PATEL, Kamala Sultansingh YADAV, Jayant Kumar MANDAL, Kirti Bansidhar MAHESHWARI